Ychou M, Rivoire M, Thezenas S, Guimbaud R, et al. Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial. Br J Cancer 2022 Jan 6. pii: 10.1038/s41416-021-01644.
PMID: 34992255